Titan Pharmaceuticals (NASDAQ:TTNP) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a report published on Monday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Titan Pharmaceuticals stock opened at $5.23 on Monday. The stock’s 50 day moving average price is $3.79 and its 200 day […]
More Stories
Procyon Advisors LLC Sells 3,673 Shares of Intel Co. (NASDAQ:INTC)
Procyon Advisors LLC reduced its holdings in Intel Co. (NASDAQ:INTC – Free Report) by 15.8% in the 1st quarter, Holdings...
Procyon Advisors LLC Has $490,000 Stake in Wells Fargo & Company (NYSE:WFC)
Procyon Advisors LLC grew its stake in shares of Wells Fargo & Company (NYSE:WFC) by 2.8% in the first quarter,...
Imagine Lithium (CVE:ILI) Stock Price Up 33.3% – What’s Next?
Shares of Imagine Lithium Inc. (CVE:ILI – Get Free Report) rose 33.3% during mid-day trading on Saturday . The company...
Transition Metals (CVE:XTM) Trading 62.5% Higher – Should You Buy?
Transition Metals Corp. (CVE:XTM – Get Free Report) shares were up 62.5% during mid-day trading on Saturday . The stock...
Alba Mineral Resources (LON:ALBA) Trading Down 11.1% – Here’s Why
Shares of Alba Mineral Resources plc (LON:ALBA – Get Free Report) traded down 11.1% during trading on Saturday . The...
Centurion Minerals (CVE:CTN) Shares Up 33.3% – Here’s What Happened
Centurion Minerals Ltd. (CVE:CTN – Get Free Report)’s stock price traded up 33.3% during trading on Saturday . The stock...